anonymous
Guest
anonymous
Guest
If it’s a staggered reentry. Just do company name, state and date.
Many companies are being extra careful, keeping reps out of the field. Some are not. Huge potential for spreading and liability.States need to decide when we go back in the field, not pharma companies. Because we travel from office to office and many of us travel through multiple counties on a daily basis we need to be tested frequently - how frequently? How will this be done? In over 20 years working in pharma I have not witnessed many companies that are actually patient focused - and none that I've worked for have realized that their reps are patients. Without oversight administered by officials OUTSIDE the pharma industry there's pretty good odds we will be back to square one, thrown back into the fire in the form of a nationwide swarm of traveling of typhoid marys.